Industry & Business

Malin Announces Investment in Gene Therapy Company Poseida Therapeutics, Inc.

 Breaking News
  • TechConnect Live – RDS, Dublin – May 30th, 2018 TechConnect Live, Ireland’s largest technology event, is expected to attract over 3,000 visitors from across the Irish and international tech sector to the RDS, Dublin on 30th of May 2018. TechConnect Live provides a unique forum for technology companies, start-ups, investors and the largest Irish and global end users of technology and services in order [...]...
  • Ornua Delivers Record Revenue Ornua, Ireland’s largest exporter of Irish dairy products which supplies to over 110 countries worldwide, has reported record revenue of €2.1 billion for the year ended 30 December 2017. It marks the first year of Ornua’s new five-year growth plan, ‘Ornua 2021’, which positions the business as a leading global dairy organisation that delivers results [...]...
  • EPA Welcomes Increase in Composting and Anaerobic Digestion of Waste The EPA has released data and information on composting and anaerobic digestion in Ireland for 2016. The data updates the National Waste Statistics web resource, launched by the EPA in recent months. Commenting on the figures, Stephen Treacy, EPA, said: “The EPA welcomes the increase in the amount of biodegradable waste being accepted for recycling at composting [...]...
  • Revised Research Priority Areas For 2018-2023 The Government has published the ‘Research Priority Areas 2018–2023’ report. Research Prioritisation, introduced by the Government in 2012, aligns the majority of competitively awarded public investment in research with 14 priority areas. Innovation 2020, Ireland’s strategy for research and development, science and technology, commits to reviewing the priority areas to ensure that they are still valid [...]...
  • Brexit Price Increases Could Affect Poorer Households Most A hard Brexit would increase the cost of living for all households in Ireland by 2 per cent to 3.1 per cent – an annual increase of €892 to €1,360 per household, according to the Competition and Consumer Protection Commission. Costs would rise the most for lower-income households. These households spend a greater share of [...]...

Malin Announces Investment in Gene Therapy Company Poseida Therapeutics, Inc.

Malin Announces Investment in Gene Therapy Company Poseida Therapeutics, Inc.
December 16
11:12 2015
Malin, an Irish-based company set up by a number of former Elan executives is to invest in privately held life science assets, Poseida Therapeutics.
The deal will see Malin acquire a 31pc stake in Poseida, which is working on treatments for liver disease and cancer using genome engineering described by Malin as “ground-breaking”.
Poseida is a US-based, privately-held human therapeutics company using genome engineering technologies to develop novel, life-saving treatments, including gene therapies for orphan liver diseases and immuno-oncology therapeutics for several types of cancer.

The company is currently developing gene therapies for orphan liver diseases and autologous Chimeric Antigen Receptor T-cell therapies. It also has an alliance with Janssen Biotech to develop allogeneic CAR-T therapies for the treatment of various cancers.

Under the terms of the transaction, Malin will invest $20 million in Poseida with a commitment to invest a further $10 million in 2016 subject to the achievement of certain milestones. CEO of Malin, Kelly Martin and Malin Chief Investment Officer, Adrian Howd, Ph.D, will also join the Board of Poseida.

Malin chief investment officer Adrian Howd said “Poseida offers Malin innovative science in the gene therapy, immuno-oncology and gene editing spaces, with utility across multiple therapeutic areas. Genome engineering offers a major advancement in therapy and this transaction reflects our belief that Poseida provides another best-in-class asset which will contribute to long term value for our shareholders.”

About Author



Related Articles

New Subscriber

Subscribe Here


National Manufacturing Conference & Exhibition 2018

NIBRT Springboard Success Stories

Upcoming Events

  • No upcoming events
AEC v1.0.4